Underlying prothrombotic states in pregnancy associated cerebral venous thrombosis

Neurology India

Volumn 58, Issue 4, 2010, Pages 555-559

  Aaron, S ^a   Alexander, M ^a   Maya, T ^a   Mathew, V ^a   Goel, M ^a   Nair, S C ^a   Mammen, J ^a   Vikram, M ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Cerebral venous thrombosis; factor V leiden; factor VIII; hyperhomocysteinemia; MTHFR; protein C; protein S

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5; FIBRINOLYTIC AGENT; HEPARIN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROTHROMBIN;

ADULT; ARTICLE; BRAIN EDEMA; CEREBRAL SINUS THROMBOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPILEPTIC STATE; FEMALE; FLUID INTAKE; HETEROZYGOSITY; HUMAN; MORTALITY; PREGNANCY; RISK FACTOR; VEIN THROMBOSIS; ANALYSIS OF VARIANCE; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; INTRACRANIAL THROMBOSIS; METABOLISM; PHYSIOLOGY; PREGNANCY COMPLICATION; VENOUS THROMBOSIS; WATER DEPRIVATION; YOUNG ADULT;

ADULT; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FACTOR V; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INTRACRANIAL THROMBOSIS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PROTHROMBIN; RISK FACTORS; VENOUS THROMBOSIS; WATER DEPRIVATION; YOUNG ADULT;

EID: 77956359915     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.68676     Document Type: Article

References (30)

1. Abraham J, Rao PS, Inbaraj SG. An epidemiological study of hemiplegia due to stroke in South India. Stroke 1970;1:477-481
2. Abraham J, Shetty G, Jose CJ. Strokes in the Young. Stroke 1971;2:258-267
3. Rao KB. Maternal mortality in a teaching hospital in southern India: A 13-year study. Obstet Gynecol 1975;46:397-400.
4. Srinivasan K. Cerebral venous and arterial thrombosis in pregnancy and puerperium: A study of 135 patients. Angiology 1983;34:731-746
5. Sanchetee PC, Dhamija RM, Roy AK, Venkataraman S. Peripartum cerebral venous thrombosis. J Assoc Physicians India 1992;40:664-666
6. Panagariya A, Maru A. Cerebral venous thrombosis in pregnancy and puerperium: A prospective study. J Assoc Physicians India 1997;45:857-859
7. Nagaraja D, Haridas T, Taly AB, Veerendrakumar M, Subbukrishna DK. Puerperal cerebral venous thrombosis-therapeutic benefit of low dose heparin. Neurol India 1999;47:43-46
8. Nagaraja D, Kruthika-Vinod T P, Christopher R. The prothrombin gene G20210A variant and puerperal cerebral venous and sinus thrombosis in South Indian women. J Clin Neurosci 2007;14:635-638
9. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607
10. Kumar S, Alexander M, Gnanamuthu C. Abstracts of the XIIth Annual conference. Vol.7. Annals of Indian Academy Of Neurology; 2004. p. 28.
11. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-1231
12. Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987;317:991-996
13. Cakmak S, Derex L, Berruyer M, Nighoghossian N, Philippeau F, Adeleine P, et al. Cerebral venous thrombosis-Clinical outcome and systematic screening of prothrombotic factors. Neurology 2003;60:1175-1178
14. Vora S, Ghosh K, Shetty S, Salvi V, Satoskar P. Deep venous thrombosis in the antenatal period in a large cohort of pregnancies form western India. Thromb J 2007;5:9.
15. Salomen O, David M, Steinberg A. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment. Arterioscler Thromb Vasc Biol 1999;19:511-518
16. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood 2003;102:1363-1366
17. Chambers JC, Ireland H, Thompson E, Reilly P, Obeid OA, Refsum H, et al. Methylenetetrahydrofolate Reductase 677 CT mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol 2000;20:2448-2452
18. Angeline T, Bentley HA, Hawk AB, Manners RJ, Mokashi HA, Jeyaraj N, et al. Prevalence of the Factor V G1691A and the Factor II/prothrombin G20210A gene polymorphisms among Tamilians. Exp Mol Pathol 2005;79:9-13.
19. Koshy A, Jeyakumari M. Prothrombin G20210A gene variant is not associated with idiopathic portal vein thrombosis in an area endemic for portal vein thrombosis. Ann Hematol 2006;85:126-128
20. Ghosh K, Shetty S, Madkaikar M, Pawar A, Nair S, Khare A, et al. Venous thromboembolism in young patients from western India: a study. Clin Appl Thromb Hemost 2001;7:158-165
21. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
22. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa M V, et al. Mutations in coagulation factors in women with unexplained late fetal loss. N Engl J Med 2000;343:1015-1018
23. Sanson BJ, Friederich P W, Simioni P, Zanardi S, Hilsman M V, Girolami A, et al. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost 1996;75:387-388
24. Ridker PM, Miletich J P, Buring JE, Ariyo AA, Price DT, Manson JE, et al. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 1998;128:1000-1003
25. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000;31:1274-1282
26. Griffin JH, Mosher D F, Zimmerman T, Kleiss AJ. Protein C and anti-thrombotic protein is reduced in hospitalized patients with intravascular coagulation. Blood 1982;60:261-269
27. Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CR. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995;90:725-727
28. Hellgren M, Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 1995;173:210-213
29. Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F, et al. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005;36:1720-1725
30. Aaron S, Alexander M, Thomas M, George B, Mammen J. Cerebral venous thrombosis due to homozygous factor V Leiden mutation. Neurol India 2009;57:91.